Early surgical outcome after failed primary stenting for lower limb occlusive disease

Journal of Endovascular Therapy

Volumn 12, Issue 1, 2005, Pages 13-21

  Böckler, Dittmar ^a   Blaurock, Peter ^b   Mannsman, Ulrich ^a   Schwarzbach, Matthias ^a   Seelos, Robert ^a   Schumacher, Hardy ^a   Allenberg, Jens Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM DARMSTADT   (Germany)

Author keywords

Balloon angioplasty; Bypass graft; Claudication; Critical limb ischemia; Instent restenosis; Lower limb arteries; Stent occlusion; Stents; Superficial femoral artery

Indexed keywords

ADULT; AGED; AMPUTATION; ARTERY RECONSTRUCTION; BYPASS SURGERY; CLAUDICATION; CLINICAL ARTICLE; COHORT ANALYSIS; DEEP FEMORAL ARTERY; FEMALE; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; LEG ARTERY; LEG DISEASE; LEG ISCHEMIA; LUMBAR SYMPATHECTOMY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REOPERATION; REVIEW; STENT; SURVIVAL RATE; THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; AORTOGRAPHY; ARTERIAL OCCLUSIVE DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; MALE; MIDDLE AGED; PROBABILITY; PROSTHESIS FAILURE; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 13644253782     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1252.1     Document Type: Review

References (44)

1. Vorwerk D. For the motion: Arterial stents are not required for femoropopliteal angioplasty. In: Greenhalgh RM, ed. Vascular and Endovascular Controversies. London: Biba Publishing; 2003:323-329.
2. Reekers JA. Against the motion: Arterial stents are not required for femoropopliteal angioplasty. In: Greenhalgh RM, ed. Vascular and Endovascular Controversies. London: Biba Publishing; 2003:330-333.
3. Henry M, Henry I, Klonaris C, et al. Clinical experience with the OptiMed Sinus stent in the peripheral arteries. J Endovasc Ther. 2003;10:772-779.
4. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87-96.
5. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
6. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluorethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104-114.
7. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol. 2004;7:2-5.
8. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 1999;10:499-506.
9. Papavassiliou VG, Walker SR, Bolia A, et al. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. 2003;25:125-130.
10. Franco CD, Goldsmith J, Veith FJ, et al. Management of arterial injuries produced by percutaneous femoral procedures. Surgery. 1993;113:419-425.
11. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538.
12. Ahn SS, Rutherford RB, Becker GJ, et al. Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg. 1993;17:1103-1107.
13. Duda SH, Bosiers M, Pusich B, et al. Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study. Cardiovasc Intervent Radiol. 2002;25:413-418.
14. White GH, Liew SC, Waugh RC, et al. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. J Vasc Surg. 1995;21:270-281.
15. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
16. Becquemin J-P, Favre J-P, Marzelle J, et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487-494.
17. Sullivan TM, Childs MB, Bacharach JM, et al. Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients. J Vasc Surg. 1997;25:829-839.
18. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther. 2003;10:619-628.
19. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311.
20. Thierry B, Tabrizian M. Biocompatibility and biostability of metallic endovascular implants: state of the art and perspectives. J Endovasc Ther. 2003;10:807-824.
21. Inoue S, Koyama H, Miyata T, et al. Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease. J Vasc Surg. 2002;35:672-678.
22. Vroegindeweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
23. Grimm J, Muller-Hulsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-942.
24. Jahnke T, Voshage G, Müller-Hulsbech S, et al. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol. 2002;13:257-266.
25. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in superficial and popliteal arteries: a midterm follow-up. Radiology. 2002;222:37-43.
26. Muradin GSR, Bosch JL, Stijnen T, et al. Balloon dilatation and stent implantation for treatment of femoropopliteal arterial disease: metaanalysis. Radiology. 2001;221:137-145.
27. Schillinger M, Mlekusch W, Haumer M, et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003;10:288-297.
28. Kröger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther. 2004;11:686-694.
29. Second European Consensus Document on critical leg ischemia. Eur J Vasc Surg. 1992;6(Suppl. A):1-32.
30. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25:74-83.
31. Do DD, Triller J, Walpoth BH, et al. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol. 1992;15:306-312.
32. Katzen BT. For the motion: Drug eluting stents will revolutionize stent outcome. In: Greenhalgh RM, ed. Vascular and Endovascular Controversies. London: Biba Publishing; 2003;335-342.
33. Duda SH, Poerner TC, Wiesinger B, et al. Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol. 2003;14:291-301.
34. Kastrati A, Schomig A, Dirschinger J, et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation. 2000;102:2593-2598.
35. Wohrle J, Al-Khayer E, Grotzinger U, et al. Comparison of the heparin coated vs the uncoated Jostent: no influence on restenosis or clinical outcome. Eur Heart J. 2001;22:1808-1816.
36. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
37. Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000;36:2325-2332.
38. Farb A, John M, Acampado E, et al. Oral everolimus inhibits in-stent neointimal growth. Circulation. 2002;106:2379-2384.
39. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
40. Virmani R, Kolodgie FD, Dake MD, et al. Histopathological evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol. 1999;10:445-456.
41. Schürmann K, Haage P, Meyer J, et al. Comparison of two stent-grafts with difference porosity: in vivo studies in a sheep model. J Vasc Interv Radiol. 2000;11:493-502.
42. Duda SH, Bosiers M, Pusich B, et al. Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study. Cardiovasc Intervent Radiol. 2002;25:413-418.
43. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41-51.
44. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ. 2003;326:584-588.